World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-IPR-16007903
Date of registration: 2016-02-05
Prospective Registration: Yes
Primary sponsor: Eye and ENT Hospital of Fudan University
Public title: Postoprative analgesia effect by oxycodone hydrochlorid in laryngectomy
Scientific title: Postoprative analgesia effect by oxycodone hydrochlorid in laryngectomy
Date of first enrolment: 2016-02-06
Target sample size: oxycodone group:45;morphine group:45;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=13341
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Post-market
Countries of recruitment
China
Contacts
Name: Wenxian Li   
Address:  83 Fenyang Road, Xuhui District, Shanghai
Telephone: +86 13917426838
Email: wenxianli66@gmail.com
Affiliation: 
Name: Wenxian Li   
Address:  83 Fenyang Road, Xuhui District, Shanghai
Telephone: +86 13917426838
Email: wenxianli66@gmail.com
Affiliation:  Eye and ENT Hospital of Fudan University
Key inclusion & exclusion criteria
Inclusion criteria: Patients with full ability to communicate undergoing selective laryngectomy, ASA status I-II, aged 20-69 years old, no restriction on gender
Exclusion criteria: 1. Patients allergic to oxycodone hydrochlorid or any drugs used during this study;
2. patients on long-term therapy with narcosis analgeticsedative or non-steroid anti-inflammatory drugs;
3. patients with neuromuscular disorders;
4. patients with allergic disorders;
5. other situations unsuitable for this study


Age minimum: 20
Age maximum: 69
Gender: Both
Health Condition(s) or Problem(s) studied
post operative pain
Intervention(s)
oxycodone group:patient-controlled intravenous analgesia with oxycodone hydrochlorid;morphine group:patient-controlled intravenous analgesia with morphine hydrochlorid;
Primary Outcome(s)
drug consumption;drug recruitment;total bolus;VAS scores;
Secondary Outcome(s)
Ramsay scores;SBP,DBP,MAP,HR,SpO2;cough scores;Nausea scores;vomiting scores;
Secondary ID(s)
Source(s) of Monetary Support
Personal
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history